Clinical Trial Update: A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting on the safety and tolerability of PEP005 Topical Gel for actinic keratosis on the top of the hand, with the study status listed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PEP005 Topical Gel (ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED